REQUEST A DEMO
Total
USD $0.00
Search more companies

Cyc-Urologia S.A.S. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Cyc-Urologia S.A.S. Profile Updated: June 16, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Cyc-Urologia S.A.S. is based in Ecuador, with the head office in Cuenca. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The enterprise was incorporated on April 12, 2022. It currently has a total number of 4 (2024) employees. From the latest financial highlights, Cyc-Urologia S.A.S. reported a net sales revenue drop of 20.39% in 2024. During that time, Cyc-Urologia S.A.S.’s total assets grew by 3.71%. The net profit margin of Cyc-Urologia S.A.S. increased by 14.13% in 2024.

Headquarters
Calle Alfonso Moreno Mora, 2-179
Cuenca; Azuay;

Contact Details: Purchase the Cyc-Urologia S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Cyc-Urologia S.A.S. report to view the information.
Registered Capital:
Purchase the Cyc-Urologia S.A.S. report to view the information.
Financial Auditors:
Purchase the Cyc-Urologia S.A.S. report to view the information.
Incorporation Date:
April 12, 2022
Key Executives
Purchase this report to view the information.
General Manager
Company Performance
Financial values in the chart are available after Cyc-Urologia S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-20.39%
Total operating revenue
-20.39%
Operating profit (EBIT)
218.49%
EBITDA
-9%
Net Profit (Loss) for the Period
165.71%
Total Assets
3.71%
Total Equity
6.69%
Operating Profit Margin (ROS)
19.47%
Net Profit Margin
14.13%
Return on Equity (ROE)
3.75%
Quick Ratio
5.98%
Cash Ratio
5.17%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?